Sygnomics
Ashutosh Tiwary is an accomplished entrepreneur and technology leader with extensive experience in the fields of cloud computing, biotechnology, and education. As Co-Founder and CEO of Sygnomics, Tiwary focuses on personalized precision oncology, leveraging advanced systems biology to improve cancer treatment outcomes. Tiwary also serves as Entrepreneur In Residence at the Institute for Systems Biology, aiding in the development of biotech companies, and as Managing Partner at Clarity Advisory LLC, providing consulting for startups and educational institutions. Previous leadership roles include Senior Vice President at Western Governors University, where Tiwary aimed to enhance access to technology education, and Vice President at Teradata, where Tiwary led the Intellicloud business. An accomplished professional, Tiwary has a strong academic background with degrees from the Birla Institute of Technology and Science, Texas A&M University, and the University of Washington.
This person is not in any teams
Sygnomics
SYGNOMICS aims to help clinicians improve patient outcomes at scale by accurately applying systems biology to cancer care. SYGNOMICS is developing an end-to-end solution that uses a unique and disruptive approach to enable personalized precision medicine for cancer patients. This solution will be powered by the Systems Genetics Network AnaLysis (SYGNAL) technology, which can accurately risk stratify a patient and personalize therapies (drugs and drug combinations) based on the unique characteristics of transcriptional “programs” underlying their disease.